-
1.
公开(公告)号:AT105301T
公开(公告)日:1994-05-15
申请号:AT89105371
申请日:1981-08-22
Applicant: HOECHST AG
-
公开(公告)号:CS409591A3
公开(公告)日:1992-04-15
申请号:CS409591
申请日:1991-12-27
Applicant: HOECHST AG
Inventor: URBACH HANSJORG DR , HENNING RAINER DR , TEETZ VOLKER DR , GEIGER ROLF PROF DR , BECKER REINHARD DR , GAUL HOLGER
IPC: A61K38/55 , A61K31/40 , A61K31/403 , A61K31/404 , A61K38/00 , A61P7/10 , A61P9/08 , A61P9/12 , C07D209/02 , C07D209/08 , C07D209/32 , C07D209/34 , C07D209/42 , C07D209/52 , C07D215/22 , C07D215/227 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06
Abstract: 1. Claims for the Contracting states ; BE, CH, DE, FR, GB, IT, Li, Lu, NL, SE A compound of the formula I see diagramm : EP0084164,P21,F7 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts. 1. Claims for the Contracting state : Austria A process for the preparation of the compounds of the formula I see diagramm : EP0084164,P24,F4 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts, which a) comprises reacting a compound of the formula II see diagramm : EP0084164,P24,F6 wherein R1 , R2 , X, Y and Z have the meanings as in formula I, with a compound of the formula III see diagramm : EP0084164,P25,F1 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2 and W denotes a radical which can be cleaved off by hydrogenolysis or by acid, and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or b) for the preparation of compounds of the formula I, in which Y and Z together denote oxygen, comprises b1 ) reacting a compound of the formula IV see diagramm : EP0084164,P25,F3 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n and R1 have the meanings as in formula I and W has the meaning as in formula III, with a compound of the formula V, R2 O2 C-CH = CH-CO-X wherein R2 and X have the meanings as in formula I, and subsequently splitting off the radical W and, if appropriate, also the radical R2 to form the free carboxyl groups, or, b2 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the general formula VI, wherein R2 has the meaning as in formula I, and with a compound of the general formula VII OHC-CO2 R2 X-CO-CH3 wherein X has the meaning as in formula I, subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl group, or c) for the preparation of compounds of the formula I, in which Y and Z each denote hydrogen, comprises c1 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the formula VIII see diagramm : EP0084164,P25,F2 wherein R2 and X have the meanings as in formula I, reducing the Schiff's bases obtained and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or c2 ) catalytically reducing a compound of the formula I in which Y and Z together denote oxygen, with hydrogen, or d) for the preparation of compounds of the formula I, in which Y denotes hydroxyl and Z denotes hydrogen, comprises reducing a compound of the formula I, in which Y and Z together denote oxygen, catalytically with hydrogen or with a reducing agent, such as sodium borohydride, and, if appropriate, converting the compounds obtained according to (a)-(d) into their physiologically acceptable salts.
-
公开(公告)号:AT52791T
公开(公告)日:1990-06-15
申请号:AT84111058
申请日:1984-09-17
Applicant: HOECHST AG
Inventor: GRAU ULRICH DR , GEIGER ROLF PROF DR , OBERMEIER RAINER DR
-
公开(公告)号:DE3280014D1
公开(公告)日:1989-12-14
申请号:DE3280014
申请日:1982-12-24
Applicant: HOECHST AG
Inventor: URBACH HANSJORG DR , HENNING RAINER DR , TEETZ VOLKER DR , GEIGER ROLF PROF DR , BECKER REINHARD DR , GAUL HOLGER
IPC: A61K38/55 , A61K31/40 , A61K31/403 , A61K31/404 , A61K38/00 , A61P7/10 , A61P9/08 , A61P9/12 , C07D209/02 , C07D209/08 , C07D209/32 , C07D209/34 , C07D209/42 , C07D209/52 , C07D215/22 , C07D215/227 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06
Abstract: 1. Claims for the Contracting states ; BE, CH, DE, FR, GB, IT, Li, Lu, NL, SE A compound of the formula I see diagramm : EP0084164,P21,F7 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts. 1. Claims for the Contracting state : Austria A process for the preparation of the compounds of the formula I see diagramm : EP0084164,P24,F4 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts, which a) comprises reacting a compound of the formula II see diagramm : EP0084164,P24,F6 wherein R1 , R2 , X, Y and Z have the meanings as in formula I, with a compound of the formula III see diagramm : EP0084164,P25,F1 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2 and W denotes a radical which can be cleaved off by hydrogenolysis or by acid, and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or b) for the preparation of compounds of the formula I, in which Y and Z together denote oxygen, comprises b1 ) reacting a compound of the formula IV see diagramm : EP0084164,P25,F3 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n and R1 have the meanings as in formula I and W has the meaning as in formula III, with a compound of the formula V, R2 O2 C-CH = CH-CO-X wherein R2 and X have the meanings as in formula I, and subsequently splitting off the radical W and, if appropriate, also the radical R2 to form the free carboxyl groups, or, b2 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the general formula VI, wherein R2 has the meaning as in formula I, and with a compound of the general formula VII OHC-CO2 R2 X-CO-CH3 wherein X has the meaning as in formula I, subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl group, or c) for the preparation of compounds of the formula I, in which Y and Z each denote hydrogen, comprises c1 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the formula VIII see diagramm : EP0084164,P25,F2 wherein R2 and X have the meanings as in formula I, reducing the Schiff's bases obtained and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or c2 ) catalytically reducing a compound of the formula I in which Y and Z together denote oxygen, with hydrogen, or d) for the preparation of compounds of the formula I, in which Y denotes hydroxyl and Z denotes hydrogen, comprises reducing a compound of the formula I, in which Y and Z together denote oxygen, catalytically with hydrogen or with a reducing agent, such as sodium borohydride, and, if appropriate, converting the compounds obtained according to (a)-(d) into their physiologically acceptable salts.
-
公开(公告)号:DE3633114A1
公开(公告)日:1988-03-31
申请号:DE3633114
申请日:1986-09-30
Applicant: HOECHST AG
Inventor: BECKER REINHARDT DR , GEIGER ROLF PROF DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
Abstract: The pharmaceutical preparation consists of an angiotensin converting enzyme inhibitor and of a diuretic of the thiazide type.
-
公开(公告)号:AT31719T
公开(公告)日:1988-01-15
申请号:AT84112848
申请日:1980-09-13
Applicant: HOECHST AG
Inventor: GEIGER ROLF PROF DR , TEETZ VOLKER DR , SCHOELKENS BERNWARD DR , WISSMANN HANS DR
IPC: A61K31/40 , A61K31/47 , C07D209/42 , C07D215/48 , C07D401/12
-
公开(公告)号:AT23441T
公开(公告)日:1986-11-15
申请号:AT80106211
申请日:1980-10-11
Applicant: HOECHST AG
Inventor: BICKEL MARTIN DR , GEIGER ROLF PROF DR , TEETZ VOLKER DR , OBERMEIER RAINER DR
-
公开(公告)号:AT21118T
公开(公告)日:1986-08-15
申请号:AT83102337
申请日:1983-03-10
Applicant: HOECHST AG
Inventor: OBERMEIER RAINER DR , GEIGER ROLF PROF DR , GRAU ULRICH DR
-
公开(公告)号:AT18550T
公开(公告)日:1986-03-15
申请号:AT82110070
申请日:1982-11-02
Applicant: HOECHST AG
Inventor: TEETZ VOLKER DR , GEIGER ROLF PROF DR , URBACH HANSJOERG DR , BECKER REINHARD DR , SCHOELKENS BERNWARD DR
IPC: A61K31/40 , C07D209/52 , C07C101/28 , C07C101/34
-
公开(公告)号:DE3268716D1
公开(公告)日:1986-03-06
申请号:DE3268716
申请日:1982-11-20
Applicant: HOECHST AG
Inventor: KONIG WOLFGANG DR , GEIGER ROLF PROF DR , OBERMEIER RAINER DR , MULLNER HUBERT DR
IPC: A61K38/22 , A61K38/00 , A61P31/04 , A61P31/12 , A61P35/00 , A61P37/00 , A61P43/00 , C07K7/06 , C07K14/66 , A61K37/02
Abstract: A peptide of the formula B1-B2-A1-A2-X in which B1 denotes a basic aminoacid, B2 denotes a basic aminoacid, A1 denotes an aromatic aminoacid, A2 denotes an aromatic aminoacid and X denotes an aminoacid in which the carboxyl group can be esterified, a process for the preparation thereof and the use thereof.
-
-
-
-
-
-
-
-
-